Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Submitted by
admin
on November 11, 2010 - 6:39pm
Source:
Bloomberg
News Tags:
lupus
Human Genome Sciences
M&A
Benlysta
Headline:
Human Genome May Be Takeover Target If U.S. Approves Lupus Drug Benlysta
Do Not Allow Advertisers to Use My Personal information
